EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›OPTH

OPTH

Optimi Health Corp.

Sell
$4.09
▲ +0.74%
$4.09▲ +12.02%
over 1Y
L $3.03EODHDH $8.61
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.7%
1W-3.5%
1M-25.8%
3M-34.1%
YTD-40.7%
1Y+12.0%
OverviewValuationQualityFilings
Rating
Sell
Quality
—
Valuation
Fair value
Sell
Conviction
Horizon
Medium (3–12mo)

Mixed signals in the latest filings.

Optimi Health Corp. shows limited reported revenue.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-162026-06-16open ↗6-KPeriod ending 2026-06-102026-06-10open ↗6-KPeriod ending 2026-06-082026-06-08open ↗6-KPeriod ending 2026-06-022026-06-02open ↗6-KPeriod ending 2026-06-012026-06-02open ↗6-KPeriod ending 2026-05-292026-05-29open ↗SCHEDULE 13GFiling2026-05-27open ↗6-KPeriod ending 2026-05-262026-05-26open ↗424B4Filing2026-05-20open ↗EFFECTFiling2026-05-19open ↗CERTFiling2026-05-19open ↗8-A12BFiling2026-05-19open ↗

Quality score

—
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
Momentum—
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is Optimi Health Corp. (OPTH) a buy?
OPTH currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.

Sources: SEC EDGAR (CIK 0002027329, latest 6-K filed 2026-06-16) · EODHD · as of 6/28/2026, 2:10:28 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Recent news

market news →
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq UplistingBullish
finance.yahoo.com· 2026-05-20
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq UplistingBullish
finance.yahoo.com· 2026-05-20
Optimi Health prices $15M public offering and Nasdaq uplistingBullish
seekingalpha.com· 2026-05-20
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq UplistingBullish
finance.yahoo.com· 2026-05-20
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public OfferingBullish
finance.yahoo.com· 2026-03-16

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score— vs 67
Revenue growth— vs 7.1%
Net margin— vs 10.5%
Return on equity— vs 12.3%
P/E— vs 25.5